Categories
Wockhardt Limited — Updates, 04-05-2026: Press Release
04-05-2026 · 03:44 pm
Wockhardt reported a positive Q4 PBT of ₹189 Cr and full-year PBT of ₹238 Cr. Q4 revenue grew 30% to ₹965 Cr, while full-year revenue hit ₹3,373 Cr. Biotech operations soared 126% in Q4. Novel antibiotic Zaynich progressed with EMA accelerated assessment, and Miqnaf launched in India.
No comments yet. Be the first to comment!